CSPC Innovation Pharmaceutical (SHE:300765, HKG:1093) received drug registration from China's medical products administrator for ustekinumab injection.
The drug, branded as Enyike, is used to treat moderate to severe plaque psoriasis, according to Friday filings with the Shenzhen and Hong Kong bourses.
Minda (NSE:MINDACORP, BOM:538962) posted a sharp increase in its attributable consolidated profit after tax to 1.25 million Indian rupees in the fiscal fourth quarter ended March 31 from 520.3 million rupees a year ago.Earnings per share climbed to 5.21 rupees from the year-ago figure of 2.18 rupees, according to a Friday filing to the Indian stock exchanges by the auto components manufacturer.Revenue from operations in fiscal Q4 also increased to 17.0 billion rupees from 13.2 billion rupees a year earlier.The board recommended a final dividend of 0.80 rupees per share for the fiscal year ended March 31.Shares of the company jumped nearly 8% in after-market hours.
The U.S. Food and Drug Administration approved Apeloa Pharmaceutical's (SHE:000739) metoprolol succinate extended-release tablets, according to a Friday disclosure to the Shenzhen bourse.The drug is indicated for hypertension and angina pectoris or chest pain, as well as symptomatic stable chronic heart failure with dysfunction in the left ventricle, among others.
Hangzhou Flariant (SHA:605566) plans to purchase information technology equipment and servers worth up to 850 million yuan.The move is subject to shareholder approval, according to a Friday filing with the Shanghai bourse.Shares of the dye manufacturer closed 3% lower Friday.